Norges Bank Regeneron Pharmaceuticals, Inc. Transaction History

Norges Bank

$716 Trillion
Q3 2024

49 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $995 Million - $1.21 Billion	1,126,948 New	1,126,948 $1.18 Billion
Q4 2023 Feb 09, 2024	BUY	$775.18 - $881.7 $823 Million - $936 Million	1,061,803 New	1,061,803 $933 Million
Q3 2023 Nov 13, 2024	BUY	$692.45 - $844.37 $733 Million - $894 Million	1,058,752 New	1,058,752 $871 Million
Q3 2023 Nov 13, 2023	SELL	$692.45 - $844.37 $628 Million - $766 Million	-906,613 Closed	0 $0
Q2 2023 Aug 14, 2024	SELL	$700.03 - $830.35 $56.4 Million - $66.9 Million	-80,593 Reduced 7.15%	1,046,355 $752 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $618 Million - $733 Million	-882,310 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$680.49 - $826.97 $681 Million - $828 Million	1,001,113 New	1,001,113 $823 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $682 Million - $741 Million	966,467 New	966,467 $697 Million
Q3 2022 Nov 13, 2023	BUY	$573.97 - $724.32 $520 Million - $657 Million	906,613 New	906,613 $625 Million
Q2 2022 Aug 14, 2023	BUY	$548.35 - $738.84 $484 Million - $652 Million	882,310 New	882,310 $522 Million
Q1 2022 May 12, 2023	BUY	$595.12 - $698.43 $12.6 Million - $14.8 Million	21,169 Added 2.19%	987,636 $690 Million
Q1 2022 May 09, 2022	SELL	$595.12 - $698.43 $574 Million - $674 Million	-964,691 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$543.48 - $670.97 $524 Million - $647 Million	964,691 New	964,691 $609 Million
Q3 2021 Nov 14, 2022	BUY	$574.03 - $680.96 $563 Million - $668 Million	980,386 New	980,386 $593 Million
Q3 2021 Nov 05, 2021	SELL	$574.03 - $680.96 $595 Million - $706 Million	-1,036,707 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$472.8 - $558.54 $490 Million - $579 Million	1,036,707 New	1,036,707 $579 Million
Q2 2021 Aug 10, 2021	SELL	$472.8 - $558.54 $464 Million - $548 Million	-980,408 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$446.73 - $548.2 $438 Million - $537 Million	980,408 New	980,408 $464 Million
Q1 2021 May 07, 2021	SELL	$446.73 - $548.2 $469 Million - $575 Million	-1,049,117 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$478.3 - $607.98 $502 Million - $638 Million	1,049,117 New	1,049,117 $507 Million
Q4 2020 Feb 10, 2021	SELL	$478.3 - $607.98 $561 Million - $713 Million	-1,172,099 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$544.75 - $658.21 $639 Million - $771 Million	1,172,099 New	1,172,099 $656 Million
Q3 2020 Nov 10, 2020	SELL	$544.75 - $658.21 $683 Million - $825 Million	-1,253,527 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$493.32 - $643.92 $618 Million - $807 Million	1,253,527 New	1,253,527 $782 Million
Q2 2020 Aug 07, 2020	SELL	$493.32 - $643.92 $405 Million - $528 Million	-820,255 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$336.18 - $494.43 $276 Million - $406 Million	820,255 New	820,255 $401 Million
Q1 2020 May 08, 2020	SELL	$336.18 - $494.43 $275 Million - $404 Million	-816,880 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$274.13 - $376.51 $224 Million - $308 Million	816,880 New	816,880 $307 Million
Q4 2019 Feb 12, 2020	SELL	$274.13 - $376.51 $224 Million - $308 Million	-816,880 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$273.46 - $318.39 $223 Million - $260 Million	816,880 New	816,880 $227 Million
Q3 2019 Nov 08, 2019	SELL	$273.46 - $318.39 $223 Million - $260 Million	-816,880 Closed	0 $0
Q2 2019 Aug 13, 2020	BUY	$299.6 - $414.82 $245 Million - $339 Million	816,880 New	816,880 $256 Million
Q2 2019 Aug 09, 2019	SELL	$299.6 - $414.82 $240 Million - $332 Million	-800,782 Closed	0 $0
Q1 2019 May 11, 2020	BUY	$372.08 - $439.57 $6.61 Million - $7.81 Million	17,765 Added 2.27%	800,782 $329 Million
Q4 2018 Mar 04, 2019	BUY	$335.82 - $403.04 $263 Million - $316 Million	783,017 New	783,017 $292 Million
Q4 2018 Feb 08, 2019	SELL	$335.82 - $403.04 $263 Million - $316 Million	-783,017 Closed	0 $0
Q3 2018 Nov 12, 2019	BUY	$351.14 - $408.51 $275 Million - $320 Million	783,017 New	783,017 $316 Million
Q3 2018 Nov 09, 2018	SELL	$351.14 - $408.51 $291 Million - $339 Million	-830,038 Closed	0 $0
Q2 2018 Aug 12, 2019	BUY	$284.6 - $344.99 $236 Million - $286 Million	830,038 New	830,038 $286 Million
Q2 2018 Jul 23, 2018	SELL	$284.6 - $344.99 $235 Million - $285 Million	-824,959 Closed	0 $0
Q1 2018 May 15, 2019	BUY	$315.82 - $393.78 $261 Million - $325 Million	824,959 New	824,959 $284 Million
Q1 2018 May 09, 2018	SELL	$315.82 - $393.78 $251 Million - $313 Million	-795,468 Closed	0 $0
Q4 2017 Mar 05, 2018	BUY	$358.63 - $469.95 $285 Million - $374 Million	795,468 New	795,468 $299 Million
Q4 2017 Feb 09, 2018	SELL	$358.63 - $469.95 $271 Million - $356 Million	-756,712 Closed	0 $0
Q3 2017 Nov 13, 2018	BUY	$431.38 - $504.0 $326 Million - $381 Million	756,712 New	756,712 $338 Million
Q3 2017 Nov 07, 2017	SELL	$431.38 - $504.0 $335 Million - $391 Million	-776,369 Closed	0 $0
Q2 2017 Jul 24, 2018	SELL	N/A	-8,024 Reduced 1.02%	776,369 $381 Million
Q1 2017 May 11, 2018	SELL	N/A	-11,141 Reduced 1.4%	784,393 $304 Million
Q3 2016 Nov 13, 2017	BUY	N/A	795,534	795,534 $0

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

82.7M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account